PBE icon

Invesco Biotechnology & Genome ETF

86 hedge funds and large institutions have $64.6M invested in Invesco Biotechnology & Genome ETF in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less funds holding

Funds holding:

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
86
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.9M
2
$10.8M
3
$5.05M
4
$4.68M
5
$3.56M
6
$3.49M
7
$2.51M
8
$1.48M
9
$1.34M
10
$1.26M
11
$1.18M
12
$1.18M
13
$1.14M
14
$973K
15
$968K
16
$919K
17
$854K
18
$759K
19
$731K
20
$684K
21
$623K
22
$590K
23
$589K
24
$514K
25
$509K